Tag: clinical trial initiation

From IND Clinical Hold to Approval: Strategies and Timeline Management

Posted on digi By digi

From IND Clinical Hold to Approval: Strategies and Timeline Management From IND Clinical Hold to Approval: Strategic Management and Timeline Navigation Understanding IND Clinical Holds and Their Impact A clinical hold issued by the FDA on an Investigational New Drug (IND) application stops clinical research activities outright until the agency’s concerns are adequately addressed. Holds…

Read More “From IND Clinical Hold to Approval: Strategies and Timeline Management” »

Post-Approval Commitments, Regulatory Submissions and Approvals

Case Study: Successful IND for First-in-Human Study

Posted on digi By digi

Case Study: Successful IND for First-in-Human Study How One Sponsor Achieved IND Clearance for a First-in-Human Trial Background: The Investigational Product and Sponsor Profile This case study highlights a mid-sized biotechnology company preparing to enter clinical trials with a novel small-molecule kinase inhibitor. The molecule was developed to treat relapsed/refractory acute myeloid leukemia (AML) and…

Read More “Case Study: Successful IND for First-in-Human Study” »

IND (Investigational New Drug) Submissions, Regulatory Submissions and Approvals